Valproic acid Active Not Recruiting Phase 2 Trials for Smith-Magenis Syndrome Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01342692Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes